Trauma History Reported at URPS Intake: Correlation with Clinical Characteristics in 600 Patients

Patel S1, Vancavage R2, Denis T2, Ardeshna M1, Argoff C3, Feustel P1, De E4

Research Type

Clinical

Abstract Category

Pelvic Pain Syndromes

Abstract 614
Open Discussion ePosters
Scientific Open Discussion Session 106
Friday 19th September 2025
15:35 - 15:40 (ePoster Station 5)
Exhibition
Pain, other Pain, Pelvic/Perineal Prolapse Symptoms Quality of Life (QoL) Questionnaire
1. Albany Medical College, 2. Department of Urology at Albany Medical Center, 3. Department of Neurology at Albany Medical Center, 4. Department of Urology at Albany Medical College
Presenter
Links

Abstract

Hypothesis / aims of study
Trauma informed care is an important concept in pelvic medicine. This study aimed to compare clinical characteristics amongst patients who report a history of trauma at intake.
Study design, materials and methods
Comprehensive prospective electronic multidisciplinary intake data was collected sequentially on 600 patients (526 female, 63 male, and 11 transgender) presenting to a single institution’s Urogynecology and Reconstructive Pelvic Surgery and Multidisciplinary Pelvic Pain clinics. Presence of trauma history was determined from the following open-ended question on the intake questionnaire: “Is there a history of trauma/abuse you would like the team to be aware of?”. Unpaired t-tests and chi squared tests were used to correlate trauma history with other intake data such as quality of life (QOL) scores (the American Urological Association (AUA) quality of life score, Patient Health Questionnaire (PHQ 4, anxiety and depression), autonomic and neurological symptoms, sexual satisfaction (measured on a scale of 1 to 5), and presence of pelvic symptoms and pelvic pain. Open-ended patient perspectives on trauma-informed physican care were also collected.
Results
The results are viewable in Figures 1 and Figure 2.
Interpretation of results
54/600 (9%) of patients highlighted a trauma history (41 women (8%), 2 men (3%), 11 (100%) transgender) in response to the open-ended question. Of these, 38/54 (71%) reported pelvic pain, compared to 42% of patients without reported trauma (p<0.001). Autonomic symptom scores were significantly higher in those with a history of trauma (mean 9.91 ± 5.4 versus 4.0 ±  4.4, p<0.001) (Figure 1). Those volunteering a trauma history also reported higher neurological symptoms (mean 4.4 ± 2.9 versus 2.0 ± 2.4, p<0.001), depression and anxiety as measured by the PHQ4 (mean 2.2 ± 2.1 versus 1.0 ± 1.6, p<0.001), and worse AUA QOL scores (mean 4.17 ± 1.85 versus mean 3.21 ± 2.19, p<0.001). In those who were sexually active and willing to answer questiona about sexual history, satisfaction was significantly higher in those with a trauma history compared to those without (mean 3.41, N=49 versus mean 2.90, N = 354, p = 0.020). Orgasm intensity (mean 2.79, N=28 versus mean 2.49, N=250, p=0.260) was not clinically significantly different between the 2 groups (Figure 2).
Concluding message
Patients relaying a history of trauma at intake to pelvic floor disorders clinic were more likely to have autonomic symptomatology, neurological symptomatology, anxiety, depression, pelvic pain, and lower reported quality of life. Interestingly, orgasm intensity is preserved, and sexual satisfaction was higher in patients with a history of trauma who were sexually active and willing to discuss. This may be attributed to positive outcomes of therapy or selection bias.
Figure 1 Figure 1: Higher autonomic symptoms in patients relaying a history of trauma (mean 9.93, N= 54) versus no comment (mean 3.97, n=546), p = < 0.001.
Figure 2 Figure 2: Representative request from patients to the question: “Comments regarding physical exam and procedures.” Physicians may use this to learn how to be trauma informed during physical exams
Disclosures
Funding Grants: Underactive Bladder (NIDDK); Clinical Research: PI, Ironwood Pharmaceuticals Consultant: Flume catheters, Luca Biologics. Infinite MD/Consumer Medical/Alight Online 2nd Opinion Advisory Board: Ironwood Pharmaceuticals Glycologix Other:National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIDDK/NIH) Principal Investigator: Jeffrey M. Lackner, PsyD ClinicalTrials.gov ID: NCT05127616 Protocol Number: EPPIC22001 – Chair, DSMB* Stock: ERYP Doximity Clinical Trial No Subjects None
03/07/2025 08:45:00